Located in Paris at the heart of Europe's largest hospital complex, the Pitié-Salpêtrière, the Institute of Myology was established in 1996 under the initiative of an association of patients and their families, AFM-Téléthon.
Its goal is to promote the existence, recognition, and development of myology as a distinct discipline. Whether healthy, ill, injured, athletic, or aging, muscle—on which our activities and vital functions depend—has become a true model of innovation for scientific and medical research.
The Institute of Myology coordinates comprehensive patient care, fundamental research, applied research, clinical research, and education. It is an internationally recognized center participating in numerous clinical trials and studies, primarily focused on neuromuscular diseases, as well as muscle injuries related to high-level sports or aging.
GOETEBORGS UNIVERSITET
Stefan Winblad
Stefan Winblad is affiliated with the Integrative Cognitive Neuroscience Lab (ICONLab) at the University of Gothenburg. Winblad’s research focuses on neuropsychology, specifically examining how diseases, injuries, and congenital variations impact cognition and emotional functioning. His ongoing studies involve assessing cognitive impairments in individuals with neuromuscular and neurological disorders, as well as gene carriers of neuromuscular diseases. Additionally, he contributes to the development and evaluation of measurement tools for assessing cognition, emotion, and social cognition
Sanofi Genzyme
Ricardo Mondragon Gonzalez
Ricardo is a Senior Scientist in the Rare and Neurologic Diseases Therapeutic Area at Sanofi, dedicated to developing therapeutic alternatives for rare neuromuscular disorders. He brings extensive experience in the pharmaceutical industry, having previously worked at Novartis and Biogen. Ricardo is deeply invested in unraveling the underlying biology of neuromuscular diseases to enable the discovery of novel therapeutic targets and potential biomarkers. He values strong collaborations with academic partners, recognizing the power of synergy in accelerating progress for the benefit of patients.
